Pajjiż: Irlanda
Lingwa: Ingliż
Sors: HPRA (Health Products Regulatory Authority)
CEFALONIUM
Zoetis Ireland Limited
QJ51D
CEFALONIUM
250 Milligram
intramammary Suspension
POM
Bovine
OTHER BETA-LACTAM ANTIBACTERIALS FOR INTRAMAMMARY USE
Antibacterial
Authorised
2015-08-07
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE VETERINARY MEDICINAL PRODUCT BOVICEF DC 250 mg Intramammary Suspension for Cattle 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each 3 g intramammary syringe contains: ACTIVE SUBSTANCE: Cefalonium 250 mg (as cefalonium dihydrate). For the full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Intramammary Suspension Off-white to brownish suspension. 4 CLINICAL PARTICULARS 4.1 TARGET SPECIES Cattle (dry cow) 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES For the treatment of subclinical mastitis at drying-off and the prevention of new bacterial infections of the udder during the non-lactating period of cows caused by _Staphylococcus aureus, Streptococcus agalactiae, Streptococcus_ _dysgalactiae, Streptococcus uberis, Trueperella pyogenes, Escherichia coli _and _Klebsiella _spp_._ 4.3 CONTRAINDICATIONS Do not use in animals with known hypersensitivity to cephalosporins, other -lactam antibiotics or to any of the excipients. 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES None. HEALTH PRODUCTS REGULATORY AUTHORITY ________________________________________________________________________________________________________________________ _Date Printed 16/11/2015_ _CRN 7021952_ _page number: 1_ 4.5 SPECIAL PRECAUTIONS FOR USE Special precautions for use in animals Use of the product should be based on susceptibility testing of the bacteria isolated from the animal. If this is not possible, therapy should be based on local (regional, farm level) epidemiological information about susceptibility of the target bacteria. Use of the product deviating from the instructions given in the SPC may increase the prevalence of bacteria resistant to the cefalonium and may decrease the effectiveness of treatment with other beta lactams. The efficacy of the product is only establi Aqra d-dokument sħiħ